Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; ...

See Atea Pharmaceuticals, Inc. (AVIR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.